These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 12887101)

  • 1. Immunoregulation by Vbeta specific antibodies in myasthenia gravis: mining physiological T cell homeostasis for TCR specific therapy.
    Jambou F; Cohen-Kaminsky S
    Cell Mol Biol (Noisy-le-grand); 2003 Mar; 49(2):181-92. PubMed ID: 12887101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating regulatory anti-T cell receptor antibodies in patients with myasthenia gravis.
    Jambou F; Zhang W; Menestrier M; Klingel-Schmitt I; Michel O; Caillat-Zucman S; Aissaoui A; Landemarre L; Berrih-Aknin S; Cohen-Kaminsky S
    J Clin Invest; 2003 Jul; 112(2):265-74. PubMed ID: 12865414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospects for a T-cell receptor vaccination against myasthenia gravis.
    Cohen-Kaminsky S; Jambou F
    Expert Rev Vaccines; 2005 Aug; 4(4):473-92. PubMed ID: 16117705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TCR-Vbeta usage in the thymus and blood of myasthenia gravis patients.
    Navaneetham D; Penn AS; Howard JF; Conti-Fine BM
    J Autoimmun; 1998 Dec; 11(6):621-33. PubMed ID: 9878084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational design of peptide vaccines for autoimmune disease: harnessing molecular recognition to fix a broken network.
    Weathington NM; Blalock JE
    Expert Rev Vaccines; 2003 Feb; 2(1):61-73. PubMed ID: 12901598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice.
    Berlo SE; Guichelaar T; Ten Brink CB; van Kooten PJ; Hauet-Broeren F; Ludanyi K; van Eden W; Broeren CP; Glant TT
    Arthritis Rheum; 2006 Aug; 54(8):2423-33. PubMed ID: 16869010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-idiotypic regulatory responses induced by vaccination with DNA encoding murine TCR Valpha5 and Vbeta2.
    Wu Y; Zhang Y; Xu X; Lv P; Gao X
    Cell Mol Immunol; 2007 Aug; 4(4):287-93. PubMed ID: 17764619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TCR vaccination in aluminum adjuvant protects against autoimmune encephalomyelitis.
    Aroeira LS
    Clin Immunol; 2006 Jun; 119(3):252-60. PubMed ID: 16503420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TCR down-regulation controls T cell homeostasis.
    Boding L; Bonefeld CM; Nielsen BL; Lauritsen JP; von Essen MR; Hansen AK; Larsen JM; Nielsen MM; Odum N; Geisler C
    J Immunol; 2009 Oct; 183(8):4994-5005. PubMed ID: 19801521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The autoimmune T and B cell repertoires in monozygotic twins discordant for myasthenia gravis.
    Kakoulidou M; Ahlberg R; Yi Q; Giscombe R; Pirskanen R; Lefvert AK
    J Neuroimmunol; 2004 Mar; 148(1-2):183-91. PubMed ID: 14975600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [TCR peptide vaccination for autoimmune diseases: involvement of T-T interaction between autoimmune T cells presenting TCR peptide and CD4-CD8- regulatory T cells].
    Yamamura T
    Nihon Rinsho; 1997 Jun; 55(6):1519-24. PubMed ID: 9200942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the factors inducing the development of childhood-onset myasthenia gravis using CDR3 spectratyping analysis of the TCR repertoire.
    Dokai H; Nomura Y; Fujikawa Y; Nihei K; Segawa M; Shinomiya N
    J Neuroimmunol; 2007 Jul; 187(1-2):192-200. PubMed ID: 17560663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with an immunodominant peptide of bovine type II collagen induces an anti-TCR response, and modulates the onset and severity of collagen-induced arthritis.
    Honda A; Ametani A; Matsumoto T; Iwaya A; Kano H; Hachimura S; Ohkawa K; Kaminogawa S; Suzuki K; Sercarz EE; Kumar V
    Int Immunol; 2004 May; 16(5):737-45. PubMed ID: 15096482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroimmunology I: Immunoregulation in neurological disease.
    Weiner HL; Hauser SL
    Ann Neurol; 1982 May; 11(5):437-49. PubMed ID: 6179458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the TCR: T-cell receptor and peptide-specific tolerance-based strategies for restoring self-tolerance in CNS autoimmune disease.
    Kohm AP; Turley DM; Miller SD
    Int Rev Immunol; 2005; 24(5-6):361-92. PubMed ID: 16318987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiotypic T cells specific for Morbillivirus nucleocapsid protein process and present their TCR to cognate anti-idiotypic CD8+ T cells.
    Lal G; Shaila MS; Nayak R
    Immunol Lett; 2006 Feb; 102(2):132-40. PubMed ID: 16188324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the pathogenicity of autoantigen-specific T-cell receptors.
    Burton AR; Vincent E; Arnold PY; Lennon GP; Smeltzer M; Li CS; Haskins K; Hutton J; Tisch RM; Sercarz EE; Santamaria P; Workman CJ; Vignali DA
    Diabetes; 2008 May; 57(5):1321-30. PubMed ID: 18299317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural autoantibodies to TCR public idiotopes: potential roles in immunomodulation.
    Schluter SF; Adelman MK; Taneja V; David C; Yocum DE; Marchalonis JJ
    Cell Mol Biol (Noisy-le-grand); 2003 Mar; 49(2):193-207. PubMed ID: 12887102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infections and autoimmune diseases.
    Bach JF
    J Autoimmun; 2005; 25 Suppl():74-80. PubMed ID: 16278064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.